Teknologi Kesehatan
Perusahaan Argentina yang terlibat dalam satu sektor: teknologi kesehatan
Perusahaan Argentina ini beroperasi di sektor yang sama, teknologi kesehatan. Mereka dilengkapi dengan harga, perubahan, dan statistik lainnya untuk membantu anda dalam mendapatkan detail maksimal. Daftar ini berisi saham-saham untuk strategi apa pun: mulai dari raksasa dengan kapitalisasi besar seperti ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1, pelaba teratas seperti ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD), dan masih banyak lagi. Filter daftar ini dan periksa kinerja perusahaan-perusahaan tersebut dengan cara yang nyaman.
Simbol | Kap Pasar | Harga | Perubahan % | Volume | Volume Relatif | P/E | EPS terdilusi TTM | Pertumbuhan EPS terdilusi TTM YoY | Imbal hasil dividen % TTM | Penilaian Analis |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1DR | 620.701 T ARS | 14250.000 ARS | −0.74% | 2.467 K | 1.15 | — | — | — | — | — |
| LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 620.701 T ARS | 14.000 USD | +3.70% | 65 | 0.74 | — | — | — | — | — |
 JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHSDR | 303.36 T ARS | 10242.500 ARS | −1.41% | 9.531 K | 0.36 | 85.30 | 120.07 ARS | +108.91% | 0.89% | — |
| JNJ.BJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 303.36 T ARS | 10500.000 ARS | −20.99% | 2.511 K | 0.07 | 87.45 | 120.07 ARS | +108.91% | 0.89% | — |
| DJN3BJOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 303.36 T ARS | 1147.500 ARS | +0.48% | 1 M | 2.65 | — | — | — | — | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 303.36 T ARS | 1197.000 ARS | −1.89% | 4 | 0.00 | — | — | — | — | — |
| JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 303.36 T ARS | 10.100 USD | −0.98% | 1.42 K | 1.71 | 68.00 | 120.07 ARS | −50.87% | 0.89% | — |
 MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50)DR | 276.102 T ARS | 26571.000 ARS | −1.12% | 967 | 1.50 | — | — | — | — | — |
| MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 276.102 T ARS | 26.000 USD | 0.00% | 20 | 4.08 | — | — | — | — | — |
 ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COMDR | 252.895 T ARS | 17441.000 ARS | −0.17% | 11.462 K | 9.17 | 21.73 | 802.79 ARS | −6.12% | 1.01% | — |
| ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 252.895 T ARS | 17.700 USD | −5.85% | 49 | 0.42 | 17.82 | 802.79 ARS | −77.92% | 1.01% | — |
 AZNASTRAZENECA CEDEAR EACH REP 0.5 ADR USD0.25DR | 182.355 T ARS | 36516.000 ARS | −0.64% | 54 | 0.09 | 175.58 | 207.98 ARS | +257.80% | 1.16% | — |
| AZNDASTRAZENECA CEDEAR EA RE 0.5 ADR (USD) DR | 182.355 T ARS | 36.750 USD | −0.27% | 5 | 0.70 | 142.85 | 207.98 ARS | −15.86% | 1.16% | — |
 TMOTHERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1DR | 181.646 T ARS | 26432.500 ARS | −2.22% | 17 | 0.12 | — | — | — | — | — |
 NVSNOVARTIS AG CEDEAR EACH 4 REP 1DR | 160.312 T ARS | 24670.000 ARS | −1.71% | 5 | 0.07 | — | — | — | — | — |
| NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD) DR | 160.312 T ARS | 23.100 USD | −3.95% | 6 | 1.03 | — | — | — | — | — |
 ABTABBOTT LABORATORIES CEDEAR EACH 4 REP 1DR | 159.788 T ARS | 28160.000 ARS | −4.69% | 546 | 0.93 | 114.52 | 245.89 ARS | +55.35% | 0.55% | — |
| ABTDABBOTT LABORATORIES CEDEAR EAC 4 REP 1(USD) DR | 159.788 T ARS | 28.000 USD | 0.00% | 1 | 0.10 | 92.05 | 245.89 ARS | −63.47% | 0.55% | — |
 PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05DR | 124.818 T ARS | 6759.000 ARS | −2.20% | 13.482 K | 0.57 | — | — | — | — | — |
| PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 124.818 T ARS | 6.580 USD | −3.24% | 510 | 0.58 | — | — | — | — | — |
 AMGNAMGEN INC CEDEAR EACH 30 REP 1DR | 123.061 T ARS | 9379.500 ARS | −1.41% | 461 | 0.22 | — | — | — | — | — |
| AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD) DR | 123.061 T ARS | 9.400 USD | −3.59% | 4 | 0.08 | — | — | — | — | — |
 MDTMEDTRONIC PLC CEDEAR EACH 4 REP 1DR | 91.308 T ARS | 21059.500 ARS | −1.22% | 44 | 0.20 | — | — | — | — | — |
 BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1DR | 84.313 T ARS | 17007.500 ARS | −2.05% | 149 | 0.40 | — | — | — | — | — |
| BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 84.313 T ARS | 17.500 USD | +2.04% | 6 | — | — | — | — | — | — |
 GILDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 COM USD0.001DR | 72.574 T ARS | 17802.000 ARS | −1.97% | 662 | 1.44 | — | — | — | — | — |
| GILDDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD) DR | 72.574 T ARS | 16.950 USD | −1.74% | 14 | 1.03 | — | — | — | — | — |
 GSKGSK PLC CEDEAR EACH REPR 1/4 ADRDR | 70.961 T ARS | 10567.000 ARS | −1.59% | 179 | 0.67 | 54.38 | 194.30 ARS | −31.41% | 1.40% | — |
| GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD) DR | 70.961 T ARS | 10.200 USD | −8.52% | 100 | 5.21 | 42.44 | 194.30 ARS | −83.87% | 1.40% | — |
 BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005DR | 24.289 T ARS | 15750.000 ARS | −2.88% | 495 | 1.14 | — | — | — | — | — |
| BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 24.289 T ARS | 20.000 USD | +2.04% | 18 | 2.69 | — | — | — | — | — |
 PHGKONINKLIJKE PHILIPS NV CEDEAR EACH REPR 1/5 ADRDR | 15.974 T ARS | 4276.000 ARS | −2.62% | 1.029 K | 0.73 | — | — | — | — | — |
 RICHLABORATORIOS RICHMOND SACIF | 72.676 B ARS | 900.000 ARS | +1.12% | 1.438 K | 0.15 | — | −130.78 ARS | — | 0.00% | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 4.344 B ARS | 102.000 ARS | −0.97% | 1.159 K | 0.18 | — | — | — | 0.00% | — |